The Danish company on Saturday announced plans to increase production of its vaccine Jynneos on the heels of the World Health Organization last week declaring mpox a global health emergency.
SIGA Technologies’ TPOXX did not outperform placebo at resolving lesions in patients with clade I mpox, the new strain that has spread through parts of Africa and is reaching beyond the continent.
Psychedelic drug developers are undeterred by the FDA’s Complete Response Letter for Lykos’ MDMA therapy for PTSD, and experts expect the company will ultimately obtain approval.
BioNTech on Monday said the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on an early stage study of its experimental cancer drug.
Omnichannel marketing has emerged as a crucial strategy for brands navigating the dynamic contemporary healthcare landscape. However, it is often misunderstood as a complex and an overwhelming task by marketers since they must bring together a range of platforms, handle large amounts of data, and ensure consistent messaging.
Just months after a jury ordered payment to Pfizer in the patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the lawsuit involving AstraZeneca’s blockbuster lung cancer drug.